
Tram T. Tran, MD, and Robert S. Brown, Jr., MD, MPH, discuss new agents for the treatment of chronic hepatitis B and how they might fit in the treatment landscape.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recount the results of clinical studies of investigational treatments for chronic hepatitis B
- Describe the resistance profiles of emerging agents for the treatment of chronic viral hepatitis B
- Identify current hepatitis B virus management strategies that may change as a result of current drugs in development